Cholinergic Drugs for Alzheimer's Disease: From Central Cholinergic Neurotransmission to Drug Therapies and Natural Products with Multitarget Actions - Image 1

£135.52

Academic Press Cholinergic Drugs for Alzheimer's Disease: From Central Cholinergic Neurotransmission to Drug Therapies and Natural Products with Multitarget Actions

Name: Cholinergic Drugs for Alzheimer's Disease: From Central Cholinergic Neurotransmission to Drug Therapies and Natural Products with Multitarget Actions
Brand: Academic Press
Price: 135.52 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

It has never been this cheap. We have no record of a lower price.

£136 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price

Price Analysis

Most common price: £136 (23 days, 100.0%)

Price range: £136 - £136

Price levels: 1 different prices over 23 days

Description

Cholinergic Drugs for Alzheimer’s Disease: From Central Cholinergic Neurotransmission to Drug Therapies and Natural Products with Multitarget Actions addresses the urgent need for advanced resources in neuropharmacology. The first section presents mechanistic insights into cholinergic drugs, current hypotheses for Alzheimer’s Disease progression, neurotransmitter systems, receptor biology, and the evolution of acetylcholinesterase inhibitors, including hybrid and multi-target drugs. It also covers clinical status, neuromuscular blockers, non-adrenergic neurotransmitters, protein kinase inhibitors, inflammation modulation, NMDA antagonism, biomarkers, and AI-assisted drug discovery. The second section explores natural alkaloidal and non-alkaloidal compounds, molecular docking, SAR analysis, and daily consumable resources, with the third section investigating marine-derived AChE inhibitors, dual- and multi-target drug concepts, and emerging therapeutic compounds. This book equips the scientific community with a robust foundation for understanding and innovating in Alzheimer’s Disease therapy. By integrating molecular biology, pharmacology, and computational approaches, it empowers researchers and clinicians to address treatment challenges, optimize drug design, and leverage natural products for multifactorial intervention. Explores cholinesterase inhibitors for cognitive improvement Summarizes receptor mechanisms in cholinergic transmission Reviews marine and plant-derived AChE inhibitors for innovative treatments Presents emerging drug therapies and multitarget natural compounds for Alzheimer’s Disease

Product Specifications

Brand: Academic Press
Format: paperback
ASIN: 0443458448
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 22 May 2026
Listed Since: 03 December 2025

Barcode

No barcode data available

Academic Press Cholinergic Drugs for Alzheimer's Disease: From Central Cholinergic Neurotransmission to Drug Therapies and Natural Products with Multitarget Actions

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Cholinergic Stress and Anxiety Signals involve Alternative Splicing

Academic Press - Alzheimer's Disease and Drug Delivery Strategies

Springer - Pharmacological Treatment of Alzheimer's Disease

Pharmacological Treatment of Alzheimer's Disease: Scientific and Clinical Aspects

Pathobiology of Alzheimer's Disease

Alzheimer’s Disease: Diagnosis, Molecular Targets, and Therapeutic Modalities

Humana Alzheimer's Disease: Methods and Protocols 2561 Book

Alzheimer's Disease - Allied Health Press Medical Book

Nicotinic Acetylcholine Receptors in Health and Disease

Signaling Molecules as Biomarkers and Therapeutic Targets for Alzheimer's Disease: A New Perspective

Academic Press - Differentiating Factors in Alzheimer's Disease

Alzheimer's Disease: Past, Present and Future

Alzheimer's Disease: 2 (Topics in Medicinal Chemistry, 2)

Academic Press - Gold Nanoparticle Therapeutics in Alzheimer's

Metabolic and Degenerative Diseases of the Central Nervous System: Pathology, Biochemistry, and Genetics

COVID-19 in Alzheimer's Disease and Dementia

Molecular Research of Alzheimer's Disease

Alzheimer's Disease: The 21st Century Challenge

Academic Press Brain Energy Metabolism in Alzheimers - Vol 188

Neuroglia in Alzheimer's Disease

Academic Press Brain Energy Metabolism in Alzheimers Disease

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

Neuropsychology of Alzheimer's Disease and Other Dementias